{"id":279322,"date":"2026-02-11T21:21:08","date_gmt":"2026-02-11T21:21:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/279322\/"},"modified":"2026-02-11T21:21:08","modified_gmt":"2026-02-11T21:21:08","slug":"more-than-a-third-of-patients-on-wegovy-pill-are-new-to-glp-1-drugs-study-finds","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/279322\/","title":{"rendered":"More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds"},"content":{"rendered":"<p class=\"col-body mb-4 leading-7 text-[18px] md:leading-8 break-words min-w-0 charcoal-color\">By Robin Respaut<\/p>\n<p class=\"col-body mb-4 leading-7 text-[18px] md:leading-8 break-words min-w-0 charcoal-color\">SAN FRANCISCO, Feb 11 (Reuters) &#8211; Among \u200cearly users of Novo \u200cNordisk&#8217;snew Wegovy weight-loss pill, 36% \u200bhad no prior experience taking a GLP-1 medication, a new study from \u200cthe health \u2060data firm Truveta found.<\/p>\n<p class=\"col-body mb-4 leading-7 text-[18px] md:leading-8 break-words min-w-0 charcoal-color\">Of patients who started \u2060a new pill prescription, 21.1% had previously \u200btaken the injectable \u200bversion \u200bof Wegovy \u200cand 15.8% switched from Eli Lilly&#8217;s Zepbound, another injectable GLP-1 medicine, according to Truveta data.<\/p>\n<p class=\"col-body mb-4 leading-7 text-[18px] md:leading-8 break-words min-w-0 charcoal-color\">Truveta reviewed health \u200crecords from 8,762 \u200bpatients with \u200bevidence \u200bof a prescription \u200cfor the new Wegovy \u200bpill, \u200bwhich was approved by the U.S. Food and \u200bDrug \u200cAdministration on December 22.<\/p>\n<p class=\"col-body mb-4 leading-7 text-[18px] md:leading-8 break-words min-w-0 charcoal-color\">(Reporting \u200bby Robin RespautEditing by \u200bBill Berkrot)<\/p>\n","protected":false},"excerpt":{"rendered":"By Robin Respaut SAN FRANCISCO, Feb 11 (Reuters) &#8211; Among \u200cearly users of Novo \u200cNordisk&#8217;snew Wegovy weight-loss pill,&hellip;\n","protected":false},"author":2,"featured_media":279323,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[134,524,111,139,14332,69],"class_list":{"0":"post-279322","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-new-zealand","11":"tag-newzealand","12":"tag-novo-nordisk","13":"tag-nz"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/279322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=279322"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/279322\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/279323"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=279322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=279322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=279322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}